Search

Your search keyword '"Simons, Brian W."' showing total 296 results

Search Constraints

Start Over You searched for: Author "Simons, Brian W." Remove constraint Author: "Simons, Brian W."
296 results on '"Simons, Brian W."'

Search Results

1. Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer

3. Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer

5. Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer

8. Role of Adenosine Deaminase in Prostate Cancer Progression

15. Figure S1 from Microparticle Encapsulation of a Prostate-targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-resistant Prostate Cancer

16. Supplementary Data from Microparticle Encapsulation of a Prostate-targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-resistant Prostate Cancer

19. Supplementary Data TS5 from Microparticle Encapsulation of a Prostate-targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-resistant Prostate Cancer

20. Supplementary Data from Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression

21. Supplemental Figures from TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis

22. Supplementary Tables S6 and S7 from Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer

23. Data from TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis

24. Data from Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression

25. Supplementary Materials and Methods from Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression

26. Supplementary Materials and Methods from TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis

27. Supplementary Figure S1 from Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer

28. Supplementary Figure S5. SPARCL-1 coated beads do not reinforce cellular traction. from Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

29. Supplementary Figure S7. Responses to SPARCL1-coated beads are concentration dependent. from Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

30. Data from Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

31. Supplementary Figure S3. The tumor microenvironment in Sparcl1-/- models. from Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

32. Supplementary Figure S6. SPARCL1 engages cell-ECM interactions. from Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

33. Supplementary Figure 6 from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

34. Supplementary Figure S2. AR directly represses SPARCL1 expression in prostate cancer. from Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

35. Supplementary Figure 2 from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

36. Supplementary Figure 7 from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

37. Supplementary Figure Legend from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

38. Supplementary Figure 5 from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

39. Supplementary Figure S4. SPARCL1 inhibits cytoskeletal remodeling. from Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

40. Supplementary Table 2 from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

41. Supplementary Figure S1. Androgen suppresses SPARCL1 expression. from Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

42. Data from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

43. Supplementary Figure 3 from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

44. Supplementary Materials and Methods and Supplementary Figure Legends from Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

45. Supplementary Figure 4 from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

46. Supplementary Figure 1 from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

47. Supplementary Table 1 from Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

50. Cover Image: Volume 83 Issue 3

Catalog

Books, media, physical & digital resources